Eli Lilly asked the FDA to authorize a Covid-19 drug that could be the first antibody treatment for patients recently diagnosed with mild to moderate cases
Eli Lilly & Co. said it has requested U.S. authorization of the emergency use of an experimental antibody-based treatment for people with recently diagnosed, mild-to-moderate Covid-19, following positive results from clinical testing.
The company said it is seeking the authorization for its drug, code named LY-CoV555, which was derived from a blood sample of one of the earliest U.S. survivors of Covid-19. The company said last month the drugLilly said Wednesday it is manufacturing doses and could have 100,000 doses this month and as many as one million by the end of the year.
Lilly also said a new study showed that combining LY-CoV555 with another antibody reduced viral load, symptoms and hospitalizations in Covid-19 patients. The company expects to seek emergency use authorization for the combination in November.that can neutralize the new coronavirus. The approach is similar to the experimental antibody-based treatment from Regeneron Pharmaceuticals that was given to President Trump.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
White House Struggles To Explain, Contain Its Own Spiraling COVID-19 CrisisAs President Trump enters his third day of aggressive and experimental COVID-19 treatment, the White House is struggling to show it has the situation under control. And inconsistencies between medical briefings and statements have only added to confusion.
Read more »
Trump and COVID-19: We need an independent commission to monitor president's health'Woodrow Wilson had a stroke that rendered him incapable of governing for the last 18 months of his presidency. His wife effectively became Commander in Chief. Americans never knew,' writes DavidBlumenthal for usatodayopinion
Read more »
White House press secretary Kayleigh McEnany tests positive for COVID-19 - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »
Trump's press secretary tests positive for COVID-19Breaking: White House Press Secretary Kayleigh McEnany announced Monday that she has tested positive for COVID-19, another sign that the pandemic that has put President Trump in the hospital is spreading through the White House
Read more »